SANUWAVE Health, Inc. (NASDAQ:SNWV) COO Peter Stegagno Sells 1,862 Shares

SANUWAVE Health, Inc. (NASDAQ:SNWV) COO Peter Stegagno sold 1,862 shares of the company’s stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $27.71, for a total value of $51,596.02. Following the completion of the sale, the chief operating officer now owns 2,032 shares of the company’s stock, valued at $56,306.72. This represents a 47.82% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

SANUWAVE Health Trading Up 8.1%

SNWV opened at $30.16 on Tuesday. The company has a market cap of $258.05 million, a price-to-earnings ratio of -6.61 and a beta of 1.19. SANUWAVE Health, Inc. has a 12 month low of $5.17 and a 12 month high of $39.50. The stock has a fifty day moving average of $29.54.

SANUWAVE Health (NASDAQ:SNWV) last released its quarterly earnings results on Friday, May 9th. The company reported ($0.66) EPS for the quarter. The firm had revenue of $9.34 million during the quarter.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in SNWV. Solas Capital Management LLC bought a new position in shares of SANUWAVE Health in the 1st quarter worth $20,658,000. AWM Investment Company Inc. acquired a new position in SANUWAVE Health during the 1st quarter valued at about $18,153,000. Goldman Sachs Group Inc. acquired a new position in SANUWAVE Health during the 1st quarter valued at about $337,000. Finally, Strategic Investment Solutions Inc. IL acquired a new position in SANUWAVE Health during the 1st quarter valued at about $47,000. 42.53% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Separately, Wall Street Zen lowered SANUWAVE Health from a “buy” rating to a “hold” rating in a research report on Saturday, May 24th.

SANUWAVE Health Company Profile

SANUWAVE Health, Inc, a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures.